Codexis (CDXS) Other Working Capital Changes (2010 - 2026)
Codexis (CDXS) posted quarterly Other Working Capital Changes of -$6.2 million for Q1 2026, down 720.4% year-over-year from $991779.5 in Q1 2025, and down 364.76% quarter-over-quarter from $2.3 million in Q4 2025.
Codexis (CDXS) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Codexis' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$6.2 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 720.4% year-over-year to -$6.2 million; the TTM figure through Mar 2026 stood at -$5.4 million (down 1017.39% YoY), while the FY2025 annual figure was $6000.0, up 250.0% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$6.2 million, down from $2.3 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $1.7 million in Q3 2025, with the low at -$2.5 million in Q2 2024.
- The 5-year median for Other Working Capital Changes is $146000.0 (2024), against an average of -$12705.9.
- Peak annual rise in Other Working Capital Changes reached 8660.0% in 2023, while the deepest fall reached 24571.43% in 2023.
- Codexis' Other Working Capital Changes stood at -$1.4 million in 2022, then jumped by 536.18% to $5.9 million in 2023, then plunged by 97.71% to $136000.0 in 2024, then surged by 1608.82% to $2.3 million in 2025, then tumbled by 364.76% to -$6.2 million in 2026.
- Business Quant data shows CDXS's Other Working Capital Changes at -$6.2 million in Q1 2026, $2.3 million in Q4 2025, and -$2.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.53 Bn | 130.68 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.34 Bn | 78.35 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.67 Bn | 59.48 Bn | 1.37 Bn |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.94 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.78 Bn | 27.47 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.81 Bn | 9.42 Bn | 668.28 Mn |
| 8 | Insmed | 27.21 Bn | 26.05 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 26.99 Bn | 26.15 Bn | - |
| 10 | Codexis | 143.86 Mn | 88.95 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -704,000.00 |
| Jun 30, 2026 | -704,000.00 |
| Jun 30, 2026 | -704,000.00 |
| Mar 31, 2026 | -1.70 Mn |
| Mar 31, 2026 | -1.70 Mn |
| Mar 31, 2026 | -1.70 Mn |
| Dec 31, 2025 | 374,000.00 |
| Dec 31, 2025 | 374,000.00 |
| Dec 31, 2025 | 374,000.00 |
| Sep 30, 2025 | 1.73 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | -374,000.00 |
| Jun 30, 2025 | -374,000.00 |
| Jun 30, 2025 | -374,000.00 |
| Mar 31, 2025 | -31,000.00 |
| Mar 31, 2025 | -31,000.00 |
| Mar 31, 2025 | -31,000.00 |
| Dec 31, 2024 | 524,000.00 |
| Dec 31, 2024 | 524,000.00 |